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ABSTRACT
We investigated how Escherichia coli ClpXP targets
the helicase-nuclease (HsdR) subunit of the bacte-
rial Type I restriction–modification enzyme EcoKI
during restriction alleviation (RA). RA is a tem-
porary reduction in endonuclease activity that oc-
curs when Type I enzymes bind unmodified recog-
nition sites on the host genome. These conditions
arise upon acquisition of a new system by a naı¨ve
host, upon generation of new sites by genome
rearrangement/mutation or during homologous re-
combination between hemimethylated DNA. Using
recombinant DNA and proteins in vitro, we demon-
strate that ClpXP targets EcoKI HsdR during dsDNA
translocation on circular DNA but not on linear DNA.
Protein roadblocks did not activate HsdR proteolysis.
We suggest that DNA translocation lifetime, which is
elevated on circular DNA relative to linear DNA, is
important to RA. To identify the ClpX degradation
tag (degron) in HsdR, we used bioinformatics and
biochemical assays to design N- and C-terminal mu-
tations that were analysed in vitro and in vivo. None
of the mutants produced a phenotype consistent with
loss of the degron, suggesting an as-yet-unidentified
recognition pathway. We note that an EcoKI nucle-
ase mutant still produces cell death in a clpx− strain,
consistent with DNA damage induced by unregulated
motor activity.
Restriction–modification (RM) systems confer selective
advantage to bacterial and archaeal cells, principally by pro-
tecting their hosts from infection by foreign DNA elements
such as bacteriophages or plasmids. For the RM systems
classified as Types I, II and III, the distinction between for-
eign and self occurs at the level of DNA recognition (1–
4); in most cases, the bacterial DNA genome is modified at
specific sites by a methyltransferase (MTase) activity whilst
incoming DNA, on which the sites are unmodified, is rec-
ognized and cleaved by a cognate nuclease activity. Driven
by their utility for host survival and against a backdrop
of counteracting evolutionary pressures, RM systems are
subject to high levels of adaptation and horizontal gene
transfer (5,6). However, the acquisition of an RM system
with a new DNA specificity presents a problem; how can
it establish when the virgin host initially has an unmodified
genome which should be recognized as ‘foreign’ and thus
subjected to double-stranded DNA (dsDNA) breaks? To
prevent these toxic events, RM systems have evolved vari-
ous control mechanisms that can transiently limit the pro-
duction of, or activity of, the nuclease until the MTase can
establish steady-state modification of the genome. Here we
investigated the molecular basis for one such control mech-
anism; the ClpXP-dependent restriction alleviation (RA) of
the Escherichia coli K Type I RM enzyme EcoKI.
Type IRM systems are assembled from three protein sub-
units (2,7): HsdS (which for EcoKI recognizes the specific
DNA sequence, 5′-AACnnnnnnGTGC-3′), HsdM (which
has N6-adenineMTase activity) and HsdR (which has both
nuclease and adenosine triphosphatase (ATPase)/helicase-
like motor activities) (Figure 1). Family subgroups (Types
1A, 1B, 1C, etc.) can be defined on the basis of amino acid
conservation and subunit complementation, with EcoKI
being a representative member of family Type IA (8). All
families assemble with the same stoichiometry, although the
relative stabilities can vary (9,10).
The most abundant cellular EcoKI complex is an S-
adenosyl methionine (AdoMet)-dependent DNA MTase
with the stoichiometry M2S1 (9,11). The less abundant
‘holoenzyme’ (R2M2S1) is active as both a DNA MTase
and a nuclease, with the balance of activities dependent
upon the nature of the DNA. DNA that is hemimethy-
lated (i.e. methylated on one or other strand following
replication of the fully modified sites) does not activate
the ATPase/helicase-like motor activity but instead elicits
maintenance methylation (12). Since EcoKI has an appre-
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Figure 1. Experimental model for ClpXP-dependent degradation of
EcoKI HsdR during translocation and cleavage of circular DNA. The
plasmid pLKS5 has a single EcoKI recognition site, as indicated. See the
main text for further details.
ciably slower de novo methylation activity, fully unmodi-
fied sites instead elicit adenosine triphosphate (ATP)-driven
bidirectional dsDNA loop translocation that leads to long-
range communication between two (or more) enzymes to
activate DNA cleavage at distant non-specific sites (13–
15). On transferring EcoKI to a naı¨ve E. coli host, it takes
∼15 generations before restriction activity can be detected,
whereas methylation activity is immediately detected (16).
The role of RA is to downregulate the endonuclease activ-
ity throughout this interlude (presumably to allow for the
slower de novo methylation) and thereafter during periods
of DNA damage stress when unmodified recognition sites
can arise on the host genome (17–28).
RA is induced whenever a Type I holoenzyme encounters
an unmodified recognition site ‘on the host genome’; cru-
cially, unmodified sites on foreign DNA (phage genomes,
plasmids, etc.) do not induceRA in vivo. In contrast to some
Type II enzymes (29–31), Type I genes are not under dif-
ferential transcriptional control (28,32). Instead RA occurs
at a post-translational level, principally through a tempo-
rary reduction in free HsdR subunits available to assem-
ble into a holoenzyme (although modulation of the MTase
activity can also occur) (23,24,26,28,33). The M2S1 com-
plex that remains can therefore complete the slow mainte-
nance methylation of the unmodified sites. RA is remark-
ably sensitive, with even small modulations in modification
activity impairing the restriction activity (25). RA has been
demonstrated for Type IA, IB, IC and ID systems in re-
sponse to homologous recombination repair of damaged
DNA (27), and to acquisition of new systems via transfor-
mation, conjugation and transduction (23). In the absence
of RA, EcoKI activity on the host DNA rapidly results in
dsDNA breaks (34).
RA occurs due to a number of different mechanisms.
For EcoKI, RA was demonstrated to be dependent on the
subunit-specific proteolysis of HsdR by ClpXP (23). ClpXP
is a hetero-oligomeric complex of anAAA+ATPase (ClpX)
and a peptidase (ClpP) (Figure 1) (35). ClpX is a chaperone
that recognizes an unstructured peptide sequence (degron)
in its substrate (or multiple copies thereof), uses ATP hy-
drolysis to unfold the tertiary protein structure and feeds
the unfolded polypeptide into a proteolytic chamber where
ClpP degrades it into small peptide fragments (Figure 1).
The ATP-dependent proteases play many important roles
in protein homeostasis and control, and are implicated in
DNA packaging, repair, replication and transcription (36–
41). In an elegant series of genetic and molecular biology
assays, NoreenMurray et al. demonstrated that ClpXP only
targets EcoKI HsdR subunits that are part of a holoen-
zyme complex capable ofATPase and translocation activity,
and that the nuclease activity of the HsdR subunit was not
necessary (23–26). ClpXP did not become activated to tar-
get HsdR subunits in trans (24), arguing against a general
SOS response. Rather, each incorrectly located transloca-
tion complex is targeted individually.
On the basis of their observations,Murray et al. proposed
a model in which the initiation of HsdR translocation is ac-
companied by a conformational change that exposes the de-
gron (Figure 1) (42). However, there is no a priori reason to
believe that the translocation mechanism on host DNA is
any different to that on foreign DNA, yet the latter does
not appear to induce RA. To provide further insight into
the mechanisms of RA, we examined the effect of ClpXP
on EcoKI DNA cleavage activity and HsdR integrity in
vitro using recombinant, purified components. Our data are
consistent with an HsdR–ClpXP interaction that requires
long-lived DNA translocation but does not require DNA
cleavage. Our observations with certain mutants shed light
on how DNA translocation, rather than nucleolytic DNA
cleavage, can influence the in vivo toxicity of Type I RM en-
zymes.
Biochemical, bioinformatics and proteomic analysis have
identified common amino acids motifs at the extreme N- or
C-termini of ClpX substrates (35,36). These signals may be
latent, only being exposed upon conformational transitions,
e.g. (43). Alternatively an adaptor protein may be required
to present the motif to ClpX, e.g. (44). The degron can also
be located at an internal site within a protein (45–47), and,
in these circumstances, may act more like an adaptor with
terminal sequences still playing a role in the initiation of
protein unfolding. Such multicomponent recognition may
be an important feature of many ClpXP targets. In the Sup-
plementary data, we also describe our attempts to unam-
biguously identify the degron(s) in EcoKI HsdR. We have
ruled out the presence of simple degrons at the HsdR ter-
mini, but could not otherwise determine the location of the
putative degron(s).
MATERIALS AND METHODS
Materials, protein preparations and DNA substrates
Oligodeoxyribonucleotides used in this study are detailed
in Supplementary Table S1 (Supplementary data). A plas-
mid with one EcoKI site and one res site for Tn21 re-
solvase (pMDS36a-Res2) was generated by removing the
177 bp XhoI-SmaI fragment from pMDS36a (48). A plas-
mid with the EcoKI removed (pLKS5-K0) was generated
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by QuikChange site-directed mutagenesis using pLKS5
(49). These DNA, plus pLKS5 (one EcoKI site), pSH1 (one
EcoKI site; two res sites) (50) and pBR322 (two EcoKI
sites) (51), were labelledwith [3H-methyl] thymidine (52). To
prepare linear DNA, pBR322, pMDS36a-Res2 and pSH1
were incubatedwithAlwNI,HindIII or EcoNI, respectively
(New England Biolabs), as instructed by the manufacturer,
and the linear DNA purified by phenol/chloroform extrac-
tion followed by ethanol precipitation. DNA concentra-
tions were determined from absorbance at 260 nm, assum-
ing an extinction coefficient of 0.02 ml/g·cm and a DNA
molecular weight of 6.6 × 105 Da/kbp.
Wild-type EcoKI MTase and HsdRN20 were pu-
rified as described previously (53). Recombinant clones
of HsdR(D298E) and HsdR(K477R) were produced by
QuikChangemutagenesis of pRSF-HsdRN20, sequenced
and the proteins expressed and purified as for the wild-type
HsdR. Holoenzyme was reconstituted immediately before
use by mixing MTase and HsdR to produce an R2M2S1
complex, as described previously (53). Tn21 resolvase was
purified as described previously (54). The production of the
DNA used in the transformation assays is described in the
Supplementary data.
To purify his-tagged ClpX, BL21 (DE3) cells (Novagen)
were first freshly transformed with the expression vector
pET14b-ClpXHis6 (55) and pLysS (Novagen) and subse-
quently grown in 4 l of Luria Broth at 30◦C to an optical
density of ∼0.6 at 600 nm. Protein expression was then in-
duced with 0.5-mM IPTG and cells were harvested after
1-h growth at 30◦C. The cell paste was resuspended in 40-
ml buffer D1 (50-mM Na-Phosphate (pH 8.0), 1-M NaCl,
10% (v/v) glycerol) and cells lysed by sonicating for 10-s
bursts for 2 min with intermittent cooling on ice (using a 3-
mm-tapered microtip at 30% amplitude and a VCX 750W
Vibra-Cell ultrasonic processor, Sonics & Materials, Inc.,
CT, USA). Cell debris was removed by centrifugation at rav
= ∼100 000 × g for 37 min at 4◦C. The supernatant was
applied to 1-g Protino Ni-IDA Resin (Macherey-Nagel),
washed three times with buffer D1 and batch eluted with
three washes of buffer D2 (50-mMNa-Phosphate (pH 8.0),
1-M NaCl, 10% (v/v) glycerol, 1-M Imidazole). Elution
fractions were dialyzed into buffer D3 (50-mM Tris (pH
8.0), 10-mMMgCl2, 10% (v/v) glycerol, 2-mMDTT) for 2 h
and applied to an anion exchange column (MonoQ 5/5GL;
GE Healthcare) equilibrated with buffer D4 (50-mM Tris
(pH 8.0), 10-mMMgCl2, 10% (v/v) glycerol, 2-mM dithio-
threitol (DTT), 50-mM KCl). Proteins were eluted with a
20-ml gradient of 50–1000-mM KCl. Fractions contain-
ing ClpX (<2 ml) were pooled and applied to a high load
16/60 Superdex 200 column equilibrated with buffer D6
(50-mM Tris (pH 8.0), 10-mM MgCl2, 10% (v/v) glyc-
erol, 2-mM DTT, 300-mM NaCl). ClpX containing frac-
tions were pooled and diluted in buffer D3 and applied to
a MonoQ 5/5GL column as before. Fractions containing
ClpX were pooled and dialyzed into storage buffer (50-mM
HEPES-KOH (pH7.5), 25-mMMgCl2, 0.1-mMethylenedi-
aminetetraacetic acid (EDTA) (pH 8.0), 200-mMKCl, 10%
(v/v) glycerol). Aliquots were frozen in liquid nitrogen and
stored at −80◦C.
To purify his-tagged ClpP, Top10 cells (Invitrogen) were
freshly transformedwith the expression vector pYK133 and
pREP-4 (56) and subsequently grown in 4 l of Luria Broth
at 37◦C to an optical density of ∼0.5 at 600 nm. Protein
expression was then induced with 0.5-mM IPTG and cells
were harvested after 3-h growth at 30◦C. The cell paste was
resuspended in 40-ml buffer D1 and cells lysed by sonicat-
ing as above for ClpX. Cell debris was removed by cen-
trifugation at rav = ∼100 000 × g for 37 min at 4◦C. The
supernatant was applied to 1 g of Protino Ni-IDA Resin,
washed three times with buffer D1 and batch eluted with
three washes of buffer D2. Elution fractions were dialyzed
into buffer D3 for 2 h and then applied to aMonoQ 5/5GL
column equilibrated with buffer D4. Bound proteins were
eluted with a 20-ml gradient from 50–1000-mMKCl. Frac-
tions containing ClpP were pooled and dialyzed into ClpP
storage buffer (50-mM Tris (pH 7.5), 25-mM MgCl2, 0.1-
mMEDTA (pH 8.0), 200-mMKCl, 1-mMDTT, 10% (v/v)
glycerol) for 2 h. Aliquots were frozen in liquid nitrogen and
stored at −80◦C.
For both ClpX and ClpP, each sample was considered
single-use and was not refrozen upon thawing. Protein con-
centration was determined using the Bio-Rad Protein Assay
according to the manufacturer’s instructions, using bovine
serum albumin (BSA) as a protein standard (Bio-Rad).
Reactions with ClpXP
Typical reactions were performed in PD buffer (25-mM
HEPES-KOH (pH 7.6), 5-mMMgCl2, 5-mMKCl, 15-mM
NaCl, 0.0032% (v/v) Triton X-100, 10% (v/v) glycerol) and
contained 5-nM DNA, 100-M S-adenosyl methionine, 4-
mM ATP, 15-U/ml creatine phosphokinase, 20-mM phos-
phocreatine, 5-nM EcoKI MTase, 40-nM EcoKI HsdR,
1-M ClpX and 2-M ClpP. Reactions were carried out
at 30◦C and started by addition of ATP. Where indicated,
Tn21 resolvase was diluted before use in 0.1-mM Tris (pH
8.0), 7.5-mM K-Glutamate, 1-M EDTA (pH 8.0), 0.1-
g/l BSA and added at 200 nM. At timed intervals fol-
lowing the addition of ATP, aliquots were removed and ei-
ther mixed 1:1 with sodium dodecyl sulphate (SDS) load-
ing buffer (100-mM Tris-Cl (pH 6.8), 2% (w/v) SDS, 20%
(v/v) glycerol, 0.1% (w/v) bromophenol blue) or 2:1 with
agarose loading buffer (40% (w/v) sucrose, 0.1-M Tris-Cl
(pH 8.0), 1-mM EDTA (pH 8.0), 0.1% (w/v) bromophe-
nol blue). SDS samples were loaded onto 10% (w/v) SDS-
polyacrylamide gel electrophoresis (PAGE) gels and run at
200 V for ∼45 min, proteins transferred to polyvinyl di-
fluoride (PVDF) membrane (Millipore) and western blot-
ting performed (see below). Agarose samples were heated
at 67◦C for 20 min then loaded on 1% (w/v) agarose gels
in TAE (40-mM Tris-acetate, 1-mM EDTA, pH 8.3) con-
taining 0.5-g/ml ethidium bromide and run at 2 V/cm
overnight to separate the DNA species. Following elec-
trophoresis DNA bands were excised from the gel and the
amount of DNA present quantified by scintillation count-
ing, where appropriate.
Western blotting
PVDF membranes (Millipore) were pre-wetted in 100%
(v/v) methanol for 5 min. The SDS-PAGE gels and PVDF
membranes were soaked in transfer buffer (10% (v/v)
 at U
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methanol, 50-mM Tris (pH 8.4)) for 30 min. Proteins were
transferred to the PVDF membrane using a BioRad Mini
Trans-Blot cell according to manufacturer’s instructions.
Following transfer, the membrane was blocked overnight
in Milk (10% (w/v) Semi-Skimmed Milk Powder (Somer-
field)) in phosphate buffered saline. Anti-EcoKI polyclonal
antibody was diluted 1:20 000 in 10% (w/v) milk solution
and incubated with the membrane for 1.5 h. The membrane
was washed three times with phosphate buffered saline sup-
plemented with 0.1% (v/v) Tween 20 for at least 5 min per
wash. Goat anti-rabbit horse radish peroxidase-conjugated
antibody (Santa Cruz Biotechnology) was diluted 1:5000 in
10% (w/v) milk solution and incubated with the membrane
for 1 h. The membrane was washed as before. To gener-
ate a chemiluminescent signal, Roche POD Western Blot-
ting substratewas used according tomanufacturer’s instruc-
tions. Visualization was performed by exposing Hyperfilm
MP (Amersham) to the blot for 20 s or 1 min (depending
on the intensity of the bands) before developing the film
with an Agfa Curix 60 film processor. Developed blots were
scanned and analysed using the Analysis Toolbox software
of ImageQuant (Amersham Biosciences, ImageQuant TL
version 2005).
RESULTS
The effect of ClpXP on nucleolytic cleavage of circular DNA
by EcoKI in vitro
We purified EcoKI HsdR and MTase separately from re-
combinant clones and reconstituted the holoenzyme in
vitro, as described previously (53). This complex has en-
zyme activities comparable to holoenzyme assembled in vivo
(9). Expression from Pres produces two forms of HsdR: a
full-length version (N19) and a version truncated by one
amino acid at the N-terminus (N20) (9). For these stud-
ies we used a recombinant clone that only produces N20;
similar results were observed with N19 (data not shown).
For consistency with previous studies, all amino acid num-
bering is based on the N-terminal methionine of the N19
species. Using recombinant clones kindly provided by Tania
Baker (Massachusetts Institute of Technology), the ClpXP
protease was reconstituted in vitro from his-tagged versions
of ClpX and ClpP (55,56), using a modified protocol (the
Materials and Methods section).
We were unable to observe any effect of ClpXP on EcoKI
using our standard EcoKI reaction buffer (data not shown).
We suspected this was due to the sensitivity of ClpXP to salt
conditions. Therefore, all subsequent experiments used an
established ClpXP buffer, PD (the Materials and Methods
section) (57). DNA cleavage by EcoKI was slower in PD
than the standard buffer. Sufficient EcoKI holoenzyme was
added so that >90% cleavage of a supercoiled DNA was
achieved within 1 h. The amount of ClpXP-dependent in-
hibition of EcoKI cleavage (see below) increased as a func-
tion of increasing ClpXP concentration. The concentra-
tions presented were the maximum achievable using avail-
able stocks and reaction volumes.We also includedAdoMet
(necessary for EcoKI nuclease activity) and an enzymatic
ATP-recycling system.
As a DNA substrate, we firstly used a 3H-labelled super-
coiled plasmid with a single EcoKI site (pLKS1; Figure 1).
Figure 2. ClpXP degrades HsdR during translocation on circular DNA
and inhibits DNA cleavage. (A) Cleavage of pLKS5 by EcoKI was moni-
tored as a function of time (0, 5, 10, 20, 40 and 60 min) in the absence or
presence of ClpXP. Reactions were initiated by the addition of ATP. Sam-
ples were separated by agarose gel electrophoresis: OC, open circle (nicked)
plasmid; D, dimeric plasmid; Lin, linear DNA; SC, supercoiled plasmid.
Graphs show quantified data: standard deviation error bars from at least
three repeat experiments. (B) Proteolysis ofHsdRwasmonitored as a func-
tion of time (0, 5, 10, 20, 40, 60 and 80 min) in the absence or presence of
ClpXP. Samples were separated by SDS gel electrophoresis and blotted us-
ing an HsdR antibody. Graphs show quantified data: standard deviation
error bars from at least three repeat experiments.
On one-site circular DNA, the two HsdR motors from a
single holoenzyme can translocate around the ring and in-
teract to cleave the DNA (Figure 1A), going via a nicked
DNA intermediate to full-length linear DNA. This prod-
uct is further randomly processed by Type I enzymes to
produce smaller linear fragments. The substrates and prod-
ucts were separated by agarose gel electrophoresis and each
species quantified by scintillation counting (the processed
fragments appear as a smear and were counted as part of
the linear band). The endonuclease activity was assessed in
the absence and presence of ClpXP (Figure 2A). With the
reaction conditions used, ClpXP irreversibly inhibited plas-
mid cleavage by EcoKI by almost 50%, consistent with its
role during RA.
To show that the inhibition of EcoKI cleavage by ClpXP
was due to proteolysis of the HsdR subunit, the same reac-
tion samples were also analysed by western blotting using
an EcoKI polyclonal antibody (kindly provided by Marie
Weiserova, Institute of Microbiology, Prague) (58). In the
presence of ClpXP, HsdR levels dropped to ∼30% after 1
h (Figure 2B). Intermediate species were not observed, con-
sistent with complete proteolysis by ClpXP following a rate-
limiting step. Degradation of theHsdM subunit was not ob-
served (Figure 3A), consistent with the earlier observations
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Figure 3. Proteolysis by ClpXP is specific to HsdR and is dependent upon
site-specific translocation by the EcoKI holoenzyme. (A) Western blot us-
ing the polyclonal HsdR antibody for 60-min EcoKI reactions on pLKS5
in the absence or presence of ClpXP. Extended exposure of the blot re-
veals cross reaction with the HsdM subunit. The graph shows quantita-
tion of the blot. (B) Example western blots (break shows different gels) for
60-min reactions under a range of conditions, using, as indicated: super-
coiled DNA (SC); DNA pre-methylated at the EcoKI site (Meth); a DNA
without an EcoKI site (Zero); or no added DNA (None). Graphs show
quantified data: standard deviation error bars from at least three repeat
experiments.
in vivo that the ClpXP interaction is specific to the HsdR
subunit. We note that the incomplete HsdR digestion may
be because those HsdR that are irreversibly trapped on the
cleaved DNA are in a different conformation that can no
longer be recognized byClpXP. Inhibition ofDNA cleavage
is likely to occur when the HsdR concentration falls below
the threshold for forming the holoenzymes (9). However,
the DNA cleavage rate in our in vitro assay is faster than
the HsdR degradation rate. This suggests that the interac-
tion of ClpXP with HsdR can inhibit the EcoKI cleavage
reaction well before actual proteolysis occurs.
Targeting of EcoKI HsdR by ClpXP is dependent on DNA
translocation but does not require DNA cleavage
To further test the model in Figure 1, we used the western
blot assay to determine the amount of HsdR degradation
after 1 h under different enzyme and substrate conditions
(Figure 3B). To test the DNA requirements, we used plas-
mid DNA substrates with an unmodified EcoKI recogni-
tion site (SC), with a site pre-methylated by EcoKI MTase
(Meth) and a plasmid DNA without an EcoKI site (Zero).
As a control, we also omitted DNA altogether (None). To
test the enzyme requirements, we omitted the MTase, the
HsdR (as a control for the blotting), ClpX or ClpP. Only
with SC DNA, the complete EcoKI holoenzyme and both
ClpX and ClpP resulted in significant HsdR degradation.
To explore the consistency between our in vitro results
and the previous in vivo observations, we also examined
Figure 4. Proteolysis ofHsdR is dependent on translocation and notDNA
cleavage. (A) Quantified data from 60-min reactions on pLKS5 in the pres-
ence or absence of ClpXP, and with EcoKI MTase without HsdR, with
wild-type HsdR or with HsdRs mutated in either a nuclease (Nuc-) or
ATPase (ATP-) motif. Standard deviation error bars from three repeat ex-
periments. (B) Transformation screen to measure RA by ClpXP. Colony
forming units (c.f.u.) were measured in separate transformation reactions
using pBR322 or plasmids carrying the complete EcoKI operon (WT), the
genes for the MTase alone (HsdR) or the EcoKI operon with an HsdR
mutated within the nuclease domain (D298E). The first two rows show the
quotient of the c.f.u. for the EcoKI plasmid and pBR322 in strains with
active ClpXP (NK311) or without active ClpXP (NK312). The third row
is the quotient of the transformation efficiency in the presence and absence
of ClpXP, with elevated values indicating ClpXP-dependent RA. The grey
box indicates that plasmid preparations from the successful transformants
showed loss of DNA in 100% of cases examined. The smaller DNA could
retransformNK312more efficiently than the originalDNA, indicating loss
of EcoKI activity.
the effect of two different HsdR mutants on ClpXP ac-
tivity (Figure 4). HsdR(D298E) is mutated in Motif II of
the RecB-family nuclease domain. A holoenzyme formed
with this HsdR (Nuc-) cannot cleave DNA but can hy-
drolyze ATP and translocate similarly to wild-type HsdR
(15,59,60). HsdR(K477R) is mutated in Motif I/Walker A
box of the Superfamily 2 helicase domain. A holoenzyme
formed with this HsdR (ATP-) cannot hydrolyze ATP, and
thus neither translocates on nor cleaves DNA (61,62). Nei-
ther mutant could cleave DNA above background (Fig-
ure 4A, upper panel). HsdR(D298E) was still degraded by
ClpXP, whilst HsdR(K477R) was not degraded, within er-
ror (Figure 4A, lower panel). These results match the obser-
vations in vivowith the samemutants (24,26) and are consis-
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tent with a requirement for DNA translocation rather than
DNA cleavage (42).
We tested RA in vivo using a transformation efficiency
assay (the method is described in more detail in the Sup-
plementary data). In brief, ClpX+ and ClpX− strains of an
EcoKI naı¨ve host were transformed with multi-copy plas-
mids carrying either thewild-typeEcoKI operon, an operon
with a truncated/inactivated hsdr, or an operon with the
D298A mutation within HsdR. The quotient of the num-
ber of colony forming units (c.f.u.) with each plasmid and
with pBR322 gives a measure of the effect of EcoKI on the
transformation efficiency; i.e. where EcoKI activity on the
genome leads to DNA damage, there is reduced cell viabil-
ity and a lower transformation efficiency relative to selec-
tion with pBR322. By comparing the ClpX+ and ClpX−
strains, we can record the effect of ClpXP as an enhance-
ment value (Figure 4B).
In the presence of EcoKI MTase alone (HsdR), there
was a 4-fold difference between the strains. However, in
the presence of the holoenzyme (WT), transformation ef-
ficiency was markedly reduced in the absence of ClpX, with
a >700-fold difference between the strains, consistent with
RA in the ClpX+ host. The few surviving ClpX− cells all
had DNA rearrangements of the EcoKI plasmid that pre-
sumably reflect selective loss of EcoKI activity. Surprisingly,
the nuclease mutant of EcoKI (D298A) also produced a
marked reduction in transformation efficiency in the ab-
sence of ClpX, with an even larger (>10 000-fold) ClpXP
enhancement. This is consistent with RA being activated
by the motor activity alone as seen previously and above,
but also demonstrates that EcoKI is toxic to naı¨ve hosts
even in the absence of nuclease activity. Presumably this re-
flects interference with cellular process by the motor activ-
ity. The greater toxicity of the nuclease mutant suggested by
the enhanced ClpXP enhancement may reflect changes in
the motor caused by mutations in the attached nuclease do-
main, which can include: decreased translocation and AT-
Pase rates; multiple enzyme populations with different char-
acteristic translocation rates; a tendency to stall during ini-
tiation; and altered HsdR turnover dynamics (63).
Cleavage of linear DNA substrates by EcoKI did not induce
HsdR degradation by ClpXP
We have shown previously that termination of Type I RM
translocation leads to rapid dissociation of HsdR from lin-
ear DNA but only very slow dissociation from circular
DNA (53). We suggested that the lifetime of the translo-
cating species is elevated on circular DNA relative to linear
DNA. To examine how this difference might affect interac-
tions with ClpXP, we repeated the DNA cleavage and west-
ern blot assays using a linear DNA with two EcoKI sites
(Figure 5A). A single EcoKI site would not support cleav-
age of linear DNA, as each HsdR would dissociate from
the DNA ends and never communicate in 1-dimension. At
least two holoenzymes must be translocating, and collide,
to activate the nuclease activity, with cleavage occurring on
average midway between the recognition sites (13).
In contrast to results on the circular DNA, ClpXP did
not inhibit the cleavage reaction on the linear DNA (in fact,
there was a slight increase in cleavage rate) and did not de-
Figure 5. Neither translocation on linear DNA nor collision with static
roadblocks stimulates ClpXP degradation of EcoKI HsdR. (A) Linear
DNA substrate used in the study. Translocation by two EcoKI holoen-
zymes is required for DNA cleavage. (B) Cleavage of the linear DNA by
EcoKI was monitored as a function of time (0, 5, 10, 20, 40, 60 and 120
min) in the absence or presence of ClpXP. Samples were separated by either
agarose gel electrophoresis (upper gel) or by SDS gel electrophoresis fol-
lowed by western blotting using an HsdR antibody. Graphs to the right of
each gel show quantified data: standard deviation error bars from at least
two repeat experiments. (C) Proteolysis of HsdR was monitored follow-
ing 120-min EcoKI reactions in the absence or presence of ClpXP on the
DNA shown. For the linear DNA with res binding sites, Tn21 resolvase
was also added where indicated. Each res site has three binding sites for
three resolvase dimers. Samples were separated as in (B).
grade the HsdR within error (Figure 5B). As noted above,
the long-lived interaction between HsdR and the cleaved
DNA does not result in HsdR degradation, suggesting a
different post-cleavage conformational state that is not rec-
ognized by ClpXP. The rate of linear DNA cleavage under
the PD buffer conditions was actually slower than the rate
of circular DNA cleavage. Therefore, the time it takes to
cleave the DNA does not appear to be directly relevant to
whether or not ClpXP can interact with HsdR. Instead it
is more likely that the important factor is the total time in
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the translocation state (rather than dissociated or cleaved
states), which is elevated on circular DNA (53).
Collision/stalling at protein roadblocks by EcoKI does not
induce HsdR degradation by ClpXP
One possible explanation for why the host genomic DNA
produces RA and foreign DNA does not is that the den-
sity of nucleoprotein complexes on the host DNA may be
greater. In the presence of roadblocks, EcoKI may stall nu-
merous times and spend longer in the translocation state
before DNA dissociation or cleavage can occur. Whilst our
results on circular DNA suggest that protein-dependent
stalling is not a prerequisite, conformational changes dur-
ing stalling with roadblocks may nonetheless increase the
chance of ClpXP interaction and increase RA efficiency.
To test this, we analysed HsdR degradation on linear DNA
in the presence of a stable site-specific roadblock (Tn21 re-
solvase bound to its res site; Figure 5C). We used two dif-
ferent linear one-site DNA substrates, with either one or
two res sites present on the translocation path. As expected,
neither of the one-site linear DNAs were cleaved by EcoKI
(data not shown). The western blot assay shows that HsdR
degradation is not activated by collisions with resolvase.
One site circular DNA without res sites was used as a con-
trol, with the expected activation ofHsdRdegradation. Sev-
eral other non-specific protein roadblocks were also tested
on the one-site linear DNA [the nucleoid-associated pro-
teins StpA and HNS], none of which showed any clear ac-
tivating effect on HsdR degradation (data not shown).
DISCUSSION
ClpXP recognizes long-lived translocation states of HsdR
We demonstrate in vitro that ClpXP will proteolyze the
HsdR subunit of EcoKI during site-specific DNA translo-
cation, independent of DNA cleavage (Figures 2–4), which
is consistent with the proposedmodel for ClpXP-dependent
RA (Figure 1) (42). No other adaptors molecules appear to
be necessary for this interaction other than those included
in our in vitro assays. We were not able to demonstrate com-
plete degradation of HsdR or complete inhibition of DNA
cleavage (Figure 2). We suspect that this may reflect the dif-
ficulty in finding in vitro conditions that are suitable for the
robust activity of both enzyme systems. Under our in vitro
assembly conditions, almost every HsdR subunit should be
part of a holoenzyme complex and thus available for in-
teraction with ClpXP (9,53). However, we cannot rule out
that partial disassembly in the modified buffer caused re-
lease of orphanHsdR subunits which thus became resistant
to ClpXP. Proteolysis of HsdR was not observed following
DNA cleavage, despite the fact that the HsdRs can remain
tightly associated with the cleaved ends and continue to hy-
drolyze ATP. This may be because there is another change
in protein conformation that shields the degron after DNA
cleavage. Alternatively, the MTase may act as an adaptor
that interacts with ClpX without being a substrate for un-
folding. The loss of the MTase following cleavage (53) will
therefore prevent ClpX interaction with the orphan HsdR.
In contrast, we did not observe HsdR proteolysis dur-
ing translocation and/or cleavage of linearDNA substrates.
This is not due to a faster linear DNA cleavage rate by
EcoKI. This is also unlikely to reflect topological differ-
ences between the substrates; we note that foreign circular
DNAs, such as M13, are efficiently restricted and do not
induce RA to any measurable extent (26). Instead we sug-
gest that the difference between circular and linear DNA in
vitro reflects a difference in relative ‘translocation lifetime’.
We previously showed HsdR motors could ‘turnover’ more
rapidly on linear DNA than circular DNA in vitro, most
likely due to dissociation from the free DNA ends (53). The
longer lifetime on circular DNA could give ClpXP a big-
ger ‘window of opportunity’ to interact compared to lin-
ear DNA. Similarly, Makovets et al. (33) previously sug-
gested that the delay between recognition of an unmodified
site on the genome and DNA damage (see below) would
allow recognition by ClpXP. Presumably this ‘window of
opportunity’ is far shorter on bacteriophage DNA, most
likely due to the higher frequency of unmodified sites per
unit length which rapidly leads to DNA cleavage follow-
ing DNA recognition. We also demonstrated that stalling
of the motor at a protein roadblock in vitro did not elevate
the translocation lifetime sufficiently to activate HsdR pro-
teolysis (Figure 5). Therefore differences in DNA packag-
ing between host and foreign DNA may be less relevant.
A definitive answer to why foreign DNA does not activate
RA really requires the direct observation of translocation
events, and even RA, in living cells.
Some Type I enzymes such as EcoR124I (Type IC) dis-
play ClpXP-independent RA (33). In this case, there is no
proteolysis and the total levels of HsdR remain constant.
Instead the pool of free HsdR available to form the R2M2S1
holoenzyme (necessary for efficient translocation and cleav-
age) appears to become diluted by the translocation events
on the genome. Mutations within EcoR124I HsdR which
reduce RA also affect the translocation efficiency by in-
creasing turnover (64). This suggests that translocation life-
time may be a general feature that is used during all types
of RA, albeit in different ways (see below).
Attempts to identify the HsdR degron were unsuccessful
A key question in the ClpXP-dependent RA scheme (Fig-
ure 1) is the identity of the degron recognized by ClpX.
Our attempts to address this are described in the Supple-
mentary data. Unfortunately, point mutations at putative
motifs within the N- and C-termini and random mutations
within HsdR did not result in clear phenotypes in either the
in vitro ClpXP assays or in vivo transformation screens. A
number of studies have pointed to more complex divalent
degrons (45–47), and it is possible that the HsdR interac-
tion requires the sole or di/multivalent use of an internal
degron. Proteomics studies that targeted ClpXP substrates
using kinetically trapped ClpP complexes from lysates of E.
coli (36) did not identify HsdR as a substrate. However, if
RA was not activated, ClpXP would not necessarily bind
to HsdR. Further studies are required to identify the HsdR
degron and to show how it is revealed during translocation.
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DNA translocation is potentially toxic but allows an addi-
tional level of control
If RA is an effective tool against self-cleavage, why has RA
not been observed for other classes of RM enzyme, many of
which are related to Type I enzymes? For example, the Type
IIB systems such as BcgI share many features (2,65): they
also use the same protein complex for both recognition and
methylation, making control more difficult; they have target
recognition domains similar to HsdS and recognize bipar-
tite DNA sequences; the MTase and nuclease domains are
structurally homologous to HsdM and the RecB-like nucle-
ase domain of HsdR, respectively; and the subunits can as-
sociate with similar holoenzyme stoichiometry (i.e. two M
and R domains per S). However, Type IIB enzymes do not
appear to be susceptible to RA. A point mutant (Y439A)
in BcgI results in an R+M−mutant that could cleave DNA
but could not methylate it (66). Expression of this mutated
form of BcgI from a constitutive promoter was lethal to the
host, presumably due to the digestion of hostDNA.Equiva-
lent mutants of Type I enzymes lead to RA (24,33). The key
difference between the Type I and IIB systems is the ATP-
dependent DNA translocation of the former catalyzed by
helicase domains which the latter do not have. We suggest
that a nucleotide triphosphate-dependent motor domain is
the key to RA.
Our results with EcoKI show that, even in the absence of
DNA cleavage, unregulated DNA translocation (and asso-
ciated motor stall states; (63)) can be toxic to a cell (Fig-
ure 4). The most likely toxic effect of a motor would be
due to collision with a replication fork (67), although other
processes such as transcription might also be disrupted.
Presumably the EcoKI HsdR motors have evolved to be
sufficiently stable during translocation that interactions on
foreign DNA have a high chance of successfully complet-
ing long-range interactions and thus DNA cleavage. The
price paid for this is that any translocation events on the
host DNA are robust and thus more likely to be disruptive.
Nonetheless, to be consistent with the ‘window of opportu-
nity’ model for ClpXP interaction (33), there must be a rea-
sonable delay between recognition of an unmodified host
site and the subsequent toxic effects of any translocation.
We speculate that RA may have evolved for Type I
enzymes to deal with ‘toxic translocation events’ rather
than nuclease-induced dsDNA breaks per se. Hence RA
is specific to Type I systems that catalyze force-generating
translocation. A recurring rhetorical question is, why do
Type I enzymes bother with extensive ATP hydrolysis for a
thermodynamically favourable reaction such asDNA cleav-
age? One possible answer is that ATP-dependent translo-
cation allows an additional level of control over the sys-
tem to prevent autotoxicity (68). In particular, the lifetime
of the translocation events may play a key role in both
ClpXP-dependent and -independent RA, even if the mech-
anistic details are quite distinct. This is an evolutionary
advantage that the Type I enzymes have over other non-
motor-based RM systems. As noted before, the widespread
distribution of mechanistically equivalent Type I systems
amongst prokaryotes (69) is not because they aremore com-
plicated, but perhaps because they are more ‘sophisticated’
(42).
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